ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Dexamethasone Improved Survival Of Leukemia

November 26, 2004

NCI Faced Pressure From Congress, HHS, White On Mammography Statement

April 11, 1997

Plans For NIH Women’s Health Study Discussed In Forum; $500 Mil. Program To Be Funded Through Contracts

November 8, 1991

Radioactive Seeds Tested In Treatment Of NSCLC

September 26, 2008

Cancer Letter Closes Out 1983, 10th Year

December 16, 1983

Ford Budget Gives NCI Same Amount As FY 1977; Carter Probably Won’t Ask For Any Increase

January 21, 1977